Cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
In this video interview with Dr Monty Pal from the [...]
In this video interview with Dr Monty Pal from the [...]
The discovery of a reliable biomarker for metastatic renal cell [...]
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
In this study, 6,043 patients with metastatic renal cell carcinoma [...]
Cabozantinib and sunitinib are both drugs that block the development [...]
Most studies have shown that many cancer patients are at [...]
In this video interview, Dr Jeffrey Kirshner from the Haematology-Oncology Associates [...]
Tivozanib is a drug that blocks the blood supply to [...]
In a major report, the NHS proposing to radically overhaul [...]
A recent retrospective study (looking back at the patients’ cases [...]